Tenax Therapeutics, Inc.
TENX
$1.83
-$0.01-0.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.36M | 23.09M | 23.71M | 20.51M | 15.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.61M | 61.62M | 56.39M | 47.23M | 35.04M |
| Operating Income | -68.61M | -61.62M | -56.39M | -47.23M | -35.04M |
| Income Before Tax | -64.86M | -57.91M | -52.60M | -43.33M | -31.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -64.86 | -57.91 | -52.60 | -43.33 | -31.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.86M | -57.91M | -52.60M | -43.33M | -31.48M |
| EBIT | -68.61M | -61.62M | -56.39M | -47.23M | -35.04M |
| EBITDA | -- | -- | -- | -7.29M | -11.91M |
| EPS Basic | -1.48 | -1.40 | -1.34 | -1.13 | -0.92 |
| Normalized Basic EPS | -0.92 | -0.87 | -0.84 | -0.71 | -0.58 |
| EPS Diluted | -1.48 | -1.40 | -1.34 | -1.13 | -0.92 |
| Normalized Diluted EPS | -0.92 | -0.87 | -0.84 | -0.71 | -0.58 |
| Average Basic Shares Outstanding | 176.75M | 165.46M | 156.82M | 151.19M | 132.61M |
| Average Diluted Shares Outstanding | 176.75M | 165.46M | 156.82M | 151.19M | 132.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |